Literature DB >> 10472781

Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7.

L K Leung1, T T Wang.   

Abstract

The present study explored the effects of three commonly used chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway and the interaction of these chemotherapeutic drugs with the estradiol-mediated regulation of this pathway. Our results showed that: (1) Treatment of MCF-7 cells with Adriamycin resulted in time- and concentration-dependent decreases in Bcl-2 and increases in Bax mRNA and protein levels. (2) Camptothecin elicited similar trends on Bcl-2 and Bax as Adriamycin, while etoposide, at 50-100 fold (1-5 microM) the effective concentration of Adriamycin and camptothecin, only resulted in an increase in Bax mRNA levels. (3) Adriamycin and camptothecin, but not etoposide, were effective in suppressing estradiol-stimulated increases in Bcl-2 mRNA levels. Our study provides evidence that the Bcl-2/Bax apoptosis pathway may be differentially regulated by chemotherapeutic agents. In addition, interaction between these agents and estradiol on the Bcl-2/Bax apoptosis pathway may also exist.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472781     DOI: 10.1023/a:1006190802590

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Down regulation of bcl2 expression in invasive ductal carcinomas is both estrogen- and progesterone-receptor dependent and associated with poor prognostic factors.

Authors:  Sung-Hye Park; Hanseong Kim; Byung-Joo Song
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 2.  Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.

Authors:  Joanne M Bowen; Rachel J Gibson; Adrian G Cummins; Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2006-02-02       Impact factor: 3.603

3.  A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model.

Authors:  Jessica E Pritchard; Patrick M Dillon; Mark R Conaway; Corinne M Silva; Sarah J Parsons
Journal:  Oncology       Date:  2012-09-05       Impact factor: 2.935

4.  Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report.

Authors:  Arsinoi Xanthinaki; Ourania Nicolatou-Galitis; Pavlina Athanassiadou; Maria Gonidi; Vassilis Kouloulias; Anastasia Sotiropoulou-Lontou; George Pissakas; Konstantinos Kyprianou; John Kouvaris; Efstratios Patsouris
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

5.  Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.

Authors:  Hong Liu; Wei Sun; Liu-Bao Gu; Yue Tu; Bing-Yin Yu; Hao Hu
Journal:  Chin J Integr Med       Date:  2015-10-10       Impact factor: 1.978

6.  Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells.

Authors:  Simin Sharifi; Jaleh Barar; Mohammad Saeid Hejazi; Nasser Samadi
Journal:  Adv Pharm Bull       Date:  2015-09-19

7.  Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence.

Authors:  Céline Douarre; Dennis Gomez; Hamid Morjani; Jean-Marie Zahm; Marie-Françoise O'donohue; Lahcen Eddabra; Patrick Mailliet; Jean-François Riou; Chantal Trentesaux
Journal:  Nucleic Acids Res       Date:  2005-04-14       Impact factor: 16.971

Review 8.  Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.

Authors:  Fernando Ezquer; Jaime Gutiérrez; Marcelo Ezquer; Christian Caglevic; Helio C Salgado; Sebastián D Calligaris
Journal:  Stem Cell Res Ther       Date:  2015-06-24       Impact factor: 6.832

9.  Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale.

Authors:  Ayman I Elkady; Osama A Abuzinadah; Nabih A Baeshen; Tarek R Rahmy
Journal:  J Biomed Biotechnol       Date:  2012-08-26

10.  Synergy of BID with doxorubicin in the killing of cancer cells.

Authors:  Emilia Joanna Orzechowska; Agnieszka Girstun; Krzysztof Staron; Joanna Trzcinska-Danielewicz
Journal:  Oncol Rep       Date:  2015-03-09       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.